Literature DB >> 7067177

Prolonged anuria and aortic insufficiency in a child with Wegener's granulomatosis.

S Dabbagh, R L Chevalier, B C Sturgill.   

Abstract

A 16 year-old boy developed generalized Wegener's granulomatosis with rapidly progressive renal insufficiency resulting in prolonged anuria. He was treated with cyclophosphamide, prednisone and anticoagulants, and was maintained on peritoneal dialysis for seven weeks, after which he regained a GFR of 35 ml/min. Recovery of renal function following prolonged anuria has not been previously reported in a child with Wegener's granulomatosis. The patient also developed aortic regurgitation, a cardiac lesion not previously described in this disorder.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7067177

Source DB:  PubMed          Journal:  Clin Nephrol        ISSN: 0301-0430            Impact factor:   0.975


  6 in total

1.  Severe granulomatous giant cell myocarditis in Wegener's granulomatosis.

Authors:  A Weidhase; H J Gröne; C Unterberg; P Schuff-Werner; V Wiegand
Journal:  Klin Wochenschr       Date:  1990-09-03

2.  Aortic valvulitis in a patient with Wegener's granulomatosis.

Authors:  R J Yanda; M S Guis; J M Rabkin
Journal:  West J Med       Date:  1989-11

Review 3.  Endocarditis associated with antineutrophil cytoplasmic antibodies: a case report and review of the literature.

Authors:  Julio A Chirinos; Vicente F Corrales-Medina; Santiago Garcia; Daniel M Lichtstein; Alan L Bisno; Simon Chakko
Journal:  Clin Rheumatol       Date:  2006-01-27       Impact factor: 2.980

Review 4.  Wegener's granulomatosis and the heart.

Authors:  S C Grant; R D Levy; M C Venning; C Ward; N H Brooks
Journal:  Br Heart J       Date:  1994-01

5.  Cardiac involvement in Wegener's granulomatosis.

Authors:  N E Goodfield; S Bhandari; W D Plant; A Morley-Davies; G R Sutherland
Journal:  Br Heart J       Date:  1995-02

Review 6.  Valvular involvement in ANCA-associated systemic vasculitis: a case report and literature review.

Authors:  Chloé Lacoste; Nicolas Mansencal; Mona Ben M'rad; Catherine Goulon-Goeau; Pascal Cohen; Loïc Guillevin; Thomas Hanslik
Journal:  BMC Musculoskelet Disord       Date:  2011-02-23       Impact factor: 2.362

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.